Expression of vascular endothelial growth factor receptors in tumor and stromal cells of tongue squamous cell carcinoma
1
조회
0
다운로드
2
인용
0
참고문헌
초록
Abstract
This study was to evaluate the expression of vascular endothelial growth factor receptors (VEGFRs) in tumor and stromal cells of tougue squamous cell carcinoma (SCC). We also wanted to characterize the differences, from the angiogenic aspect, between cancer-associated stromal cells and non-malignant stromal cells. Paraffin-embedded tumor specimens from eleven patients with tongue SCCs were studied. Immunohistochemical staining for VEGFR-1,-2, and -3 was performed on the tumor cells, stromal fibroblasts and tumor-associated macrophages of the specimens. The expression of all 3 receptors was detected in the tumor cells themselves of the biopsy specimens. All 3 receptors were also expressed on stromal cells, except that VEGFR-2 was not expressed in stromal fibroblasts. In radical excision specimens, the staining intensity for VEGFR-1, -2 in the tumor cells and VEGFR-1,-3 in the tumor-associated macrophages was significantly lower than that in the biopsy specimens (P < 0.05). By using the general marker of fibroblast and macrophage, 5B5 and CD68, respectively, we performed double immunofluorescence staining for 5B5 and each VEGFR in the stromal fibroblasts and for CD68 and each VEGFR in the tumor-associated macrophages of the radical excision specimens. We used 4 cases of fibroma and 4 cases of chronic inflammation tissue as the controls. It was found that only each marker was expressed in the control group, however, 5B5/VEGFR-1 and 5B5/VEGFR-3 in the stromal fibroblasts, and CD68/VEGFR-1 and CD68/VEGFR-3 in the tumor-associated macrophages were double stained in the radical excision specimens. Although our study used small number of specimens, the results of our study showed that in tongue SCC, in association with the angiogenesis, the stromal cells showed the activated phenotype and this was different from the nonmalignant stromal cells.
참고문헌 (20)
- "Vascular endothelial growth factor (VEGF) and its receptors", 13, pp.9~22 (1999)
- "Lymphatic versus blood vascular endothelial growth factors and receptors in humans", 55, pp.108~121 (2001)
- "Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors", 98, pp.1904~1913 (2001)
- "Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?", 45, pp.S163~S175 (2004)
- "Tumor-stroma interactions directing phenotype and progression of epithelial skin tumor cells", 70, pp.486~497 (2002)
- "Inhibition of vascular endothelial growth factor induced mitogenesis of human endothelial cells by a chimeric anti-kinase insert domain-containing receptor antibody", 136, pp.203~213 (1999)
- "The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis", 271, pp.17629~17634 (1996)
- "Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice", 95, pp.9349~9354 (1998)
- "Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma", 129, pp.882~888 (2003)
- "Prediction of delayed neck metastasis in patients with stage I", II squamous cell carcinoma of the tongue, 2002, pp.31, 227~233
- "Comparison of microvessel density with tumor associated macrophages in invasive breast carcinoma", 18, pp.3767~3770 (1998)
- "Regulation of angiogenesis and endothelial cell motility by matrix-bound fibroblasts", 3, pp.69~76 (1999)
- "High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis", 264, pp.751~758 (1999)
- "Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks", 16, pp.1316~1318 (2002)
- "Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1", 87, pp.3336~3343 (1996)
- "Flt-1, vascular endothelial growth factor receptor 1, is a novel cell surface marker for the lineage of monocytemacrophages in humans", 97, pp.785~791 (2001)
- "Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer", 90, pp.1373~1378 (2003)
- "Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy", 5, pp.101~111 (1999)
- "Biopsy specimen microvessel density is a useful prognostic marker in patients with T(2-4)M(0) esophageal cancer treated with chemoradiotherapy", 8, pp.124~130 (2002)
- "Effect of multimodality therapy on circulating vascular endothelial", 88, pp.1105~1109 (2001)